Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14673042 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Conditions: Colorectal Cancer;   Islet Cell Tumor;   Liver Cancer;   Metastatic Cancer;   Neuroendocrine Carcinoma
Interventions: Drug: isolated perfusion;   Drug: melphalan;   Procedure: conventional surgery

Indicates status has not been verified in more than two years